| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.04 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |